Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amiot

Showing results (691-700 of 823) with videos related to

Pageof 83
Sort By:
The American Journal of Pathology|November 18, 2016
Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1Faysal Elgilani, Shennen A Mao, Jaime M Glorioso, et al.
Cell Transplantation|November 28, 2018
Autologous Gene and Cell Therapy Provides Safe and Long-Term Curative Therapy in A Large Pig Model of Hereditary Tyrosinemia Type 1Raymond D Hickey, Clara T Nicolas, Kari Allen, et al.
JMIR Formative Research|April 3, 2024
Prospective Acceptability of Digital Therapy for Major Depressive Disorder in France: Multicentric Real-Life StudyOdile Amiot, Anne Sauvaget, Isabelle Alamome, et al.
Infection Prevention in Practice|January 5, 2023
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control studyAurelien Amiot, Anne Bourrier, Jean-Marc Gornet, et al.
Computers in Biology and Medicine|January 1, 2026
PLUME-OCT: A quality control tool to enhance statistical power in the analysis of biomarkers from 3D biomedical datasets of OCT imagesAlicia Milloz, Grégoire Molas, Yves Paychère, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 14, 2020
A Scoring System to Determine Patients' Risk of Colectomy Within 1 Year After Hospital Admission for Acute Severe Ulcerative ColitisGuillaume Le Baut, Julien Kirchgesner, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2021
Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohortMathieu Uzzan, Clément Bresteau, David Laharie, et al.
The American Journal of Gastroenterology|February 26, 2026
Histogenetic Classification Predicts Outcomes in 130 Adults with Chronic Intestinal Pseudo-ObstructionMinh-Chau Ta, Dominique Cazals-Hatem, Lore Billiauws, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
Alimentary Pharmacology & Therapeutics|August 3, 2018
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)Charlotte Gagnière, Anne Bourrier, Philippe Seksik, et al.
Pageof 83

Showing results (691-700 of 823) with videos related to

Sort By:
Pageof 83
The American Journal of Pathology|November 18, 2016
Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1Faysal Elgilani, Shennen A Mao, Jaime M Glorioso, et al.
Cell Transplantation|November 28, 2018
Autologous Gene and Cell Therapy Provides Safe and Long-Term Curative Therapy in A Large Pig Model of Hereditary Tyrosinemia Type 1Raymond D Hickey, Clara T Nicolas, Kari Allen, et al.
JMIR Formative Research|April 3, 2024
Prospective Acceptability of Digital Therapy for Major Depressive Disorder in France: Multicentric Real-Life StudyOdile Amiot, Anne Sauvaget, Isabelle Alamome, et al.
Infection Prevention in Practice|January 5, 2023
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control studyAurelien Amiot, Anne Bourrier, Jean-Marc Gornet, et al.
Computers in Biology and Medicine|January 1, 2026
PLUME-OCT: A quality control tool to enhance statistical power in the analysis of biomarkers from 3D biomedical datasets of OCT imagesAlicia Milloz, Grégoire Molas, Yves Paychère, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 14, 2020
A Scoring System to Determine Patients' Risk of Colectomy Within 1 Year After Hospital Admission for Acute Severe Ulcerative ColitisGuillaume Le Baut, Julien Kirchgesner, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2021
Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohortMathieu Uzzan, Clément Bresteau, David Laharie, et al.
The American Journal of Gastroenterology|February 26, 2026
Histogenetic Classification Predicts Outcomes in 130 Adults with Chronic Intestinal Pseudo-ObstructionMinh-Chau Ta, Dominique Cazals-Hatem, Lore Billiauws, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
Alimentary Pharmacology & Therapeutics|August 3, 2018
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)Charlotte Gagnière, Anne Bourrier, Philippe Seksik, et al.
Pageof 83